Why Is BioCryst Stock Trading Higher On Monday?
Monday, BioCryst Pharmaceuticals Inc BCRX reported a first-quarter earnings loss of $(0.17) per share versus the consensus estimate loss of $(0.21) per share…
Source: biztoc.com
Cryst Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cryst Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cryst Pharma Today - Breaking & Trending Today
Why Is BioCryst Stock Trading Higher On Monday? - BioCryst Pharma (NASDAQ:BCRX)
BioCryst's impressive first-quarter earnings report surpasses estimates. Sales surged to $92.8 million, primarily driven by Orladeyo revenue growth. With strong patient demand and strategic initiatives, BioCryst projects robust revenue
Source: benzinga.com
7 Best Growth Stocks to Buy and Hold for the Next 10 Years
These growth stocks could become multi-baggers in the future. Investors should consider them as they start to move at an aggressive pace.
Source: investorplace.com
Why BioCryst Pharmaceuticals Stock Is Popping Today
Author Bio A Fool since 2019, Prosper's writing focuses primarily on the healthcare sector. Passionate about teaching and learning, he enjoys helping others make better decisions about their finances -- and enjoys it just as much when they return the favor. In his free time, you'll find him curling up with a good book or doing math. What happened? Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) are trading higher on Wednesday following the company's announcement of positive news regarding its hereditary angioedema (HAE) treatment, Orladeyo. The company's stock was up...
Source: fool.com